AIDS and Behavior

, Volume 21, Issue 5, pp 1268–1277 | Cite as

Awareness and Acceptability of Pre-exposure HIV Prophylaxis Among Men Who have Sex with Men in Baltimore

  • Susan A. Fallon
  • Ju Nyeong Park
  • Christine Powell Ogbue
  • Colin Flynn
  • Danielle German
Original Paper

Abstract

This paper assessed characteristics associated with awareness of and willingness to take pre-exposure prophylaxis (PrEP) among Baltimore men who have sex with men (MSM). We used data from BESURE-MSM3, a venue-based cross-sectional HIV surveillance study conducted among MSM in 2011. Multivariate regression was used to identify characteristics associated with PrEP knowledge and acceptability among 399 participants. Eleven percent had heard of PrEP, 48% would be willing to use PrEP, and none had previously used it. In multivariable analysis, black race and perceived discrimination against those with HIV were significantly associated with decreased awareness, and those who perceived higher HIV discrimination reported higher acceptability of PrEP. Our findings indicate a need for further education about the potential utility of PrEP in addition to other prevention methods among MSM. HIV prevention efforts should address the link between discrimination and potential PrEP use, especially among men of color.

Keywords

MSM HIV PrEP Stigma Baltimore 

Resumen

Evaluamos las características asociadas con el conocimiento y la voluntad de hombres que tienen sexo con hombres (HSH) en Baltimore de tomar profilaxis de pre-exposición al VIH (PrEP, por sus siglas en inglés). Utilizamos datos de BESURE-MSM3, un estudio transversal de vigilancia del VIH realizado entre HSH en el año 2011. Se utilizó el método de regresión multivariante para identificar las características asociadas con el conocimiento y aceptabilidad de PrEP entre 399 participantes. El once por ciento habían previamente escuchado de PrEP, el 48% serian dispuestos a utilizar PrEP, y ningún participante había previamente utilizado PrEP. En el análisis multivariante, ser de la raza negra y la percepción de discriminación contra las personas que viven con el VIH fueron asociadas significativamente con la disminución del conocimiento sobre PrEP, aunque los que indicaron más alta percepción de discriminación asociada con el VIH reportaron más alta aceptabilidad de PrEP. Nuestros resultados indican la necesidad de una mayor educación sobre la utilidad potencial de PrEP, además de otros métodos de prevención del VIH entre HSH. Los esfuerzos de prevención del VIH necesitan abordar el vínculo entre la discriminación y el uso potencial de PrEP, especialmente entre HSH negros.

References

  1. 1.
    Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas—2012. HIV surveillance supplemental report 2014. 2014; 19(3). http://www.cdc.gov/hiv/pdf/surveillance_Report_vol_19_no_3.pdf
  2. 2.
    Centers for Disease Control and Prevention. HIV surveillance report, 2012. 2014. http://www.cdc.gov/hiv/pdf/statistics_2012_HIV_Surveillance_Report_vol_24.pdf
  3. 3.
    Purcell DW, Johnson CH, Lansky A, et al. Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates. Open AIDS J. 2012;6:98–107.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Centers for Disease Control and Prevention. Estimated HIV incidence in the United States, 2007– 2010. HIV Surveillance Supplemental Report 2012. 2012; 17(4). http://www.cdc.gov/hiv/pdf/statistics_hssr_vol_17_no_4.pdf.
  5. 5.
    Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2012. HIV Surveillance Report. 2012; 24. Available at: http://www.cdc.gov/hiv/pdf/statistics_2012_HIV_Surveillance_Report_vol_24.pdf.
  6. 6.
    Maryland Department of Health and Mental Hygiene. Maryland annual HIV epidemiological profile 2012. Center for HIV Surveillance, Epidemiology and Evaluation. 2015. http://phpa.dhmh.maryland.gov/OIDEOR/CHSE/SiteAssets/SitePages/statistics/Maryland%20HIV%20AIDS%20Epidemiological%20Profile2.pdf
  7. 7.
    Kelesidis T, Landovitz RJ. Preexposure prophylaxis for HIV prevention. Curr HIV/AIDS Rep. 2002;8(2):94–103.CrossRefGoogle Scholar
  8. 8.
    Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. NEJM. 2010;363(27):2587–99.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):1–5.CrossRefGoogle Scholar
  10. 10.
    Centers for Disease Control and Prevention. CDC statement on IPERGAY trial of Pre- exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men, NCHHSTP Newsroom, 2015. http://www.cdc.gov/nchhstp/newsroom/2015/IPERGAY-2015-Media-Statement.html.
  11. 11.
    Centers for Disease Control and Prevention. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011;60(3):65–8.Google Scholar
  12. 12.
    Food and Drug Administration. FDA approves first drug for reducing the risk of sexually acquired HIV infection. FDA News Press Release, July 16, 2012.Google Scholar
  13. 13.
    Yang D, Chariyalertsak C, Wongthanee A, et al. Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in northern thailand. PLoS ONE. 2013;8(10):e76650.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Al-Tayyib AA, Thrun MW, Haukoos JS, Walls NE. Knowledge of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men in denver, colorado. AIDS Behav. 2014;18(3):340–7.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS ONE. 2012;7(3):e33119.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Zhou F, Gao L, Li S, et al. Willingness to accept HIV pre-exposure prophylaxis among chinese men who have sex with men. PLoS ONE. 2012;7(3):e32329.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Leonardi M, Lee E, Tan DH. Awareness of, usage of and willingness to use HIV-pre-exposure prophylaxis among men in downtown Toronto, Canada. Int J STD AIDS. 2011;22(12):738–41.CrossRefPubMedGoogle Scholar
  18. 18.
    Liu A, Kittredge PV, Vittinghoff E, et al. Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J AIDS. 2008;47(2):241–7.Google Scholar
  19. 19.
    Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J AIDS. 2009;50(1):77–83.Google Scholar
  20. 20.
    Voetsch AC, Heffelfinger JD, Begley EB, Jafa-Bhushan K, Sullivan PS. Knowledge and use of preexposure and postexposure prophylaxis among attendees of minority gay pride events, 2005 through 2006. J AIDS. 2007;46(3):378–80.Google Scholar
  21. 21.
    Barash EA, Golden M. Awareness and use of HIV pre-exposure prophylaxis among attendees of a seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care STDS. 2011;24(11):689–91.CrossRefGoogle Scholar
  22. 22.
    Kellerman SE, Hutchinson AB, Begley EB, Boyett BC, Clark HA, Sullivan P. Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events, 2004. J AIDS. 2006;43(3):376–7.Google Scholar
  23. 23.
    Mehta SA, Silvera R, Bernstein K, Holzman RS, Aberg JA, Daskalakis DC. Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York city. Sex Transm Infect. 2011;87(4):344–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Rucinski KB, Mensah NP, Sepkowitz KA, Cutler BH, Sweeney MM, Myers JE. Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York city. AIDS Behav. 2013;17(6):2180–4.CrossRefPubMedGoogle Scholar
  25. 25.
    Aghaizu A, Mercey D, Copas A, Johnson AM, Hart G, Nardone A. Who would use PrEP? Factors associated with intention to use among MSM in London: a community survey. Sex Transm Infect. 2013;89(3):207–2011.CrossRefPubMedGoogle Scholar
  26. 26.
    Mansergh G, Koblin BA, Colfax GN, McKirnan DJ, Flores SA, Hudson SM. Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among US men who have sex with men. J AIDS. 2010;55(2):e14–6.Google Scholar
  27. 27.
    Lorente N, Fugon L, Carrieri MP, et al. Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in france. AIDS Care. 2012;24(4):468–77.PubMedGoogle Scholar
  28. 28.
    Schneider J, Kumar R, Dandona R, et al. Social network and risk-taking behavior most associated with rapid HIV testing, circumcision, and preexposure prophylaxis acceptability among high-risk indian men. AIDS Patient Care STDS. 2012;26(10):631–40.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in new york city. AIDS Patient Care STDS. 2013;27(4):248–54.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Pre-exposure Prophylaxis and predicted condom use among high-risk men who have sex with men. J AIDS. 2010;54(5):548–55.Google Scholar
  31. 31.
    Brooks RA, Landovitz RJ, Kaplan RL, Lieber E, Lee SJ, Barkley TW. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care STDS. 2012;26(2):87–94.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Young I, Li J, McDaid L. Awareness and willingness to use HIV pre-exposure prophylaxis amongst gay and bisexual men in scotland: implications for biomedical HIV prevention. PLoS ONE. 2013;8(5):e64038.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in san francisco: A mixed methods study. PLoS One. 2012;7(11):e50061.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Galea JT, Kinsler JJ, Salazar X, et al. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk peruvian populations. Int J STD AIDS. 2011;22(5):256–62.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Jackson T, Huang A, Gao X, Zhong X, Zhang Y. Cognitive. Psychosocial, and Sociodemographic Predictors of Willingness to use HIV pre-exposure prophylaxis among Chinese men who have sex with men, AIDS Behav. 2012;16(7):1853–61.PubMedGoogle Scholar
  36. 36.
    Ferreira LO, de Oliveira ES, Raymond HF, Chen SY, McFarland W. Use of time-location sampling for systematic behavioral surveillance of truck drivers in Brazil. AIDS Behav. 2008;12(4 Suppl):S32–8.CrossRefPubMedGoogle Scholar
  37. 37.
    MacKellar DA, Gallagher KM, Finlayson T, Sanchez T, Lansky A, Sullivan P. Surveillance of HIV risk and prevention behaviors of men who have sex with men: a national application of venue-based, time-space sampling. Public Health Rep. 2007;122(Suppl 1):39–47.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Raymond HF, McFarland W. Racial mixing and HIV risk among men who have sex with men. AIDS Behav. 2009;13(4):630–7.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Centers for Disease Control and Prevention. Prevalence and awareness of HIV infection among men who have sex with men—21 cities, United States, 2008. MMWR Morb Mortal Wkly Rep. 2010;59(37):1201–7.Google Scholar
  40. 40.
    German D, Sifakis F, Maulsby C, et al. Persistently high prevalence and unrecognized HIV infection among men who have sex with men in Baltimore: the BESURE Study. J Acquir Immune Defic Syndr. 2011;57(1):77–87.CrossRefPubMedGoogle Scholar
  41. 41.
    Shoptaw S, Weiss RE, Munjas B, et al. Homonegativity, substance use, sexual risk behaviors, and HIV status in poor and ethnic men who have sex with men in Los Angeles. J Urban Health. 2009;86(Suppl. 1):77–92.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Icard L. Gay black men and conflicting social identities: sexual orientation versus racial identity. J Soc Work Hum Sex. 1986;4:83–93.CrossRefGoogle Scholar
  43. 43.
    Operario D, Smith CD, Kegeles S. Social and psychological context for HIV risk in non-gay-identified African American men who have sex with men. AIDS Educ Prev. 2008;20:347–59.CrossRefPubMedGoogle Scholar
  44. 44.
    Williams JK, Wyatt GE, Resell J, Peterson J, Asuan-O’Brien A. Psychosocial issues among gay- and non-gay-identifying HIV-seropositive African American and Latino MSM. Cult Divers Ethn Minor Psychol. 2004;10:268–86.CrossRefGoogle Scholar
  45. 45.
    Dodge B, Jeffries WL, Sandfort TG. Beyond the down low: sexual risk, protection, and disclosure among at-risk black men who have sex with both men and women (MSMW). Arch Sex Behav. 2008;37(5):683–96.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Miller M, Serner M, Wagner M. Drug-using men who have sex with men as bridges for HIV and other sexually transmitted infections: sexual diversity among black men who have sex with men in an inner-city community. J Urban Health. 2005;82(1):i26–34.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Radcliffe J, Doty N, Hawkins LA, Gaskins CS, Beidas R, Rudy BJ. Stigma and sexual health risk in HIV-positive African American young men who have sex with men. AIDS Patient Care STDS. 2010;24(8):493–9.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Woodyard JL, Peterson JL, Stokes JP. ‘‘Let us go into the house of the lord’’: participation in African American churches among young African American men who have sex with men. J Pastor Care. 2000;54(4):451–60.Google Scholar
  49. 49.
    Miller RL Jr. Legacy denied: African American gay men, AIDS, and the black church. Soc Work. 2007;52(1):51–61.CrossRefPubMedGoogle Scholar
  50. 50.
    Radcliffe J, Doty N, Hawkins LA, et al. Stigma and sexual health risk in HIV-positive African American young men who have sex with men. AIDS Patient Care STDS. 2010;24(8):493–9.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Downshen N, Binns H, Garafalo R. Experiences of HIV-related stigma among young men who have sex with men. AIDS Patient Care STDS. 2009;23:371–6.CrossRefGoogle Scholar
  52. 52.
    Wright K, Naar-King S, Lam P, et al. Stigma scale revised: reliability and validity of a brief measure of stigma for HIV + youth. J Adol Health. 2007;40:96–8.CrossRefGoogle Scholar
  53. 53.
    Johnson M, Carrico A, Chesney M, et al. Internalized heterosexism among HIV-positive, gay-identified men: implications for HIV prevention and care. J Consult Clin Psych. 2008;76:829–39.CrossRefGoogle Scholar
  54. 54.
    Glick SN, Golden MR. Persistence of racial differences in attitudes toward homosexuality in the United States. J AIDS. 2010;55(4):516–23.Google Scholar
  55. 55.
    Abbas UL, Anderson RM, Mellors JW. Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLoS ONE. 2007;2(9):e875.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Siegel K, Raveis V. Perceptions of access to HIV-related information, care, and services among infected minority men. Qual Health Res. 1997;7(1):9–31.CrossRefGoogle Scholar
  57. 57.
    Malebranche DJ, Peterson JL, Fullilove RE, Stackhouse RW. Race and sexual identity: perceptions about medical culture and healthcare among black men who have sex with men. J Natl Med Assoc. 2004;96(1):97–107.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Halkitis PN, Parsons JT, Wolitski RJ, Remien RH. Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care. 2003;15(1):89–102.CrossRefPubMedGoogle Scholar
  59. 59.
    Clark JL, Long CM, Giron JM. Partner notification for sexually transmitted diseases in Peru: knowledge, attitudes, and practices in a high risk community. Sex Transm Dis. 2007;34:309–13.CrossRefPubMedGoogle Scholar
  60. 60.
    Bauermesiter JA, Meanley S, Pingel E, et al. PrEP awareness and perceived barriers among single young men who have sex aith men in the United States. Cur HIV Res. 2014;11(7):520–7.CrossRefGoogle Scholar
  61. 61.
    Cuevas AG, O’Brien K, Saha S. African American experiences in healthcare: “I always feel like I’m getting skipping over”. Health Psychol. 2016;35(9):987–95.CrossRefPubMedGoogle Scholar
  62. 62.
    Boulware LE, Cooper LA, Ratner LE, et al. Race and trust in the health care system. Public Health Rep. 2003;118(4):358–65.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Sorkin DH, Ngo-Metzger Q, De Alba I. Racial/ethnic discrimination in health care: impact on perceived quality of care. J Gen Intern Med. 2010;25(5):390–6.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Leibowitz AA, Parker KB, Rotheram-Borus MJ. A US Policy perspective on oral preexposure prophylaxis for HIV. Am J Public Health. 2011;101:982–5.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Mayer KH, Hosek S, Cohen S, Liu A, Pickett J, Warren M, Krakower D, Grant R. Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress. J Int AIDS Soc. 2015;18(4Suppl 3):19980.PubMedPubMedCentralGoogle Scholar
  66. 66.
    Centers for Disease control and Prevention. Preexopsure prophylaxis for the prevention of HIV infection in the United Stated—2014: a clinical practice guideline. http://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2014.pdf
  67. 67.
    NYS guidelines: HIV Clinical Resource. New York state guidance for the use of pre-exposure prophylaxis (PrEP) to prevent HIV transmission. 2015. http://www.hivguidelines.org/wp-content/uploads/2016/02/PrEP-Guidance_10-14-15.pdf
  68. 68.
    Underhill K, Operario D, Mayer KH. Implementation science of pre-exposure prophylaxis: preparing for public use. Curr HIV/AIDS Rep. 2010;7(4):210–9.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Lewontin RC. Sex, lies and social science. NY Rev Books. 1995;20:24–9.Google Scholar
  70. 70.
    Desai K, Sansom SL, Ackers ML, et al. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. Aids. 2008;22(14):1829–39.CrossRefPubMedGoogle Scholar
  71. 71.
    Paltiel AD, Freedberg KA, Scott CA, et al. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost effectiveness. Clin Infect Dis. 2009;48(6):806–15.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Vissers DC, Voeten HA, Nagelkerke NJ, Habbema JD, de Vlas SJ. The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study. PLoS ONE. 2008;3(5):e0277.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of EpidemiologyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  2. 2.Department of Health, Behavior and SocietyJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  3. 3.Maryland Department of Health and Mental HygieneJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA

Personalised recommendations